Table 2.
Gene | Knockout | Immune defects | Route/Dose | Impact on pathogenesis | Changes in host response | Reference |
---|---|---|---|---|---|---|
LTα | Germline | No lymph nodes | INa/2 × 105,b | ↓ Clearance from lung | ↑ Lung inflammation | Lee et al., 2000 |
↑ Latency | ↓ CD8+ T cell activation | |||||
CD40 | Germline | No germinal center formation | IN/1 × 103 | ↑ Reactivation | Willer and Speck, 2005 | |
↑ Infection of naïve B cell | ||||||
Recrudescence in lungs | ||||||
CD40 | Mixed BM chimera | IN/4 × 102 | Equal latency establishment Loss of latency in CD40-/- subset | Exclusion of CD40-/- B cells from germinal center | Kim et al., 2003 | |
BAFFR | Germline | ↓ Mature B cells Impaired Abc production | IN/1 × 104 | ↓ Latency at 30 dpid | ↓ Germinal centers | Frederico et al., 2014b |
↓ MHV68-specific Ab | ||||||
IPe/1 × 105 | ↑ Viral titer at 3 dpi, | |||||
↓ Infection from 8–30 dpi | ||||||
TLR2/9 | Germline | IN/5 × 104 | ↑ Viral load at 3 dpi | Sun et al., 2015 | ||
TLR3 | Germline | IN/1 × 103 | None | Gargano et al., 2008 | ||
TLR7 | Germline | IP/1 × 105 | None | Haas et al., 2014 | ||
TLR9 | Germline | IP/1 × 105 | ↑ Reactivation | |||
MyD88 | Germline | ↓ B cell activation | IN/1 × 103 | ↓ Latency in spleen at 16 dpi | ↓ B cell activation | Gargano et al., 2008 |
No difference in latency at 90 dpi | ↓ Germinal centers | |||||
↓ Class switching | ||||||
Delayed ab production | ||||||
IP/1 × 103 | ↑ Reactivation in PECs | |||||
↓ Reactivation in spleen | ||||||
Mixed BM f Chimera | IN/1 × 103 | ↓ Latency | ↓ MyD88-/- germinal center entry | |||
IkBaM | Viral Transgene | IN/1 × 103 | ↓ Latency establishment | Krug et al., 2007 | ||
↓ Infected lung B cells | ||||||
IP/1 × 103 | ↓ Viral titer | |||||
↓ Latency | ||||||
p50 | Germline | ↓ B cell proliferation | IN/1 × 102 | ↑ Viral titers in lung | ↓ Antibody production | Krug et al., 2009 |
↓ Ab levels | ↓ Latency at 16 dpi | ↓ Vβ4+ T cell | ||||
↓ Germinal centers | ↑ Latency over time | |||||
Recrudescence in lungs | ||||||
Mixed BM chimera | None | IN/1 × 102 | Normal lung titers | ↓ p50-/- germinal center B cell | ||
↓ Latency in p50-/- B cells | ||||||
Recrudescence in lungs | ||||||
aIN, intranasal infection under light anesthesia.
bDose described as PFU per animal.
cAb, antibody.
ddpi, days post infection.
eIP, intraperitoneal infection.
fBM, bone marrow.